Sugi Predict

Sugi Predict / Compounds / SCHEMBL3272876

SCHEMBL3272876

SCHEMBL3272876

CC(O)C(NC(C)(C)C)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.39
▸ SLC6A4 P31645 1/20 0.35
▸ CA2 P00918 4/20 0.34
▸ CA1 P00915 3/20 0.34
▸ MME P08473 1/20 0.33
▸ SLC6A3 Q01959 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ MAPT P10636 1/20 0.30
▸ PTGS1 P23219 1/20 0.30
▸ CHRNA1 P02708 1/20 0.30
▸ CHRNG P07510 1/20 0.30
▸ CHRNB1 P11230 1/20 0.30
▸ CHRNB2 P17787 1/20 0.30
▸ SLC6A2 P23975 1/20 0.30
▸ CHRNB4 P30926 1/20 0.30
▸ CHRNA3 P32297 1/20 0.30
▸ CHRNA4 P43681 1/20 0.30
▸ CHRND Q07001 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3891997 1.00 TP53 (0.39) TP53SLC6A4CA2CA1MME
SCHEMBL17169784 1.00 TP53 (0.39) TP53SLC6A4CA2CA1MME
SCHEMBL3272882 1.00 TP53 (0.39) TP53SLC6A4CA2CA1MME
Hydrochloric Acid SCHEMBL3653513 0.98 TP53 (0.38) TP53SLC6A4CA2CA1MME
Hydrochloric Acid SCHEMBL3653512 0.98 TP53 (0.38) TP53SLC6A4CA2CA1MME
SCHEMBL15922140 0.85 ALDH1A1 (0.35) TP53SLC6A4SLC6A3ALDH1A1POLB
SCHEMBL6608708 0.83 SMN1; SMN2 (0.37) TP53SLC6A3ALDH1A1
SCHEMBL17245263 0.83 SMN1; SMN2 (0.37) TP53SLC6A3ALDH1A1
SCHEMBL6608711 0.83 SMN1; SMN2 (0.37) TP53SLC6A3ALDH1A1
SCHEMBL28327488 0.81 SMN1; SMN2 (0.43) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118239879-A Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine 泰山学院 2024-06-25 — — CN claimed
CN-117820418-A Synthesis method of L-isoleucine-L-threonine (tert-butyl) -L-aspartic acid (tert-butyl) -tert-butyl ester 成都普康生物科技有限公司 2024-04-05 — — CN claimed
CN-109134314-A A kind of preparation method of polypeptide raw material N- fluorenylmethoxycarb-nyl -nyl O-tert-butyl threonine 吉尔生化（上海）有限公司 2019-01-04 — — CN claimed
CN-1026979-C One-step synthesis of tert-butyl threonine UNIV JILIN (CN) 1994-12-14 — — CN claimed
CN-1041757-A The single stage method of tert-butyl threonine is synthetic UNIV JILIN (CN) 1990-05-02 — — CN claimed
CN-121181655-B Insect short neuropeptide sNPF analogues and application thereof in pests 四川轻化工大学 2026-05-19 — — CN disclosed
CN-118239879-A Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine 泰山学院 2024-06-25 — — CN disclosed
CN-117820418-A Synthesis method of L-isoleucine-L-threonine (tert-butyl) -L-aspartic acid (tert-butyl) -tert-butyl ester 成都普康生物科技有限公司 2024-04-05 — — CN disclosed
US-20220183291-A1 COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY IN PLANTS BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. 2022-06-16 — — US disclosed
US-20210386721-A1 SUBSTITUTED PHENYLPROPENYL PYRIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL APPLICATIONS SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2021-12-16 — — US disclosed
CN-112979532-B Phthalimide compound, preparation method and application 中国药科大学 2021-10-19 — — CN disclosed
CN-112979532-A Phthalimide compound, preparation method and application 中国药科大学 2021-06-18 — — CN disclosed
EP-0951466-A2 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS Elan Pharmaceuticals, Inc. (US) 1999-10-27 — — EP disclosed
US-5852051-A Dipeptide p-amidinobenzylamides with N-terminal sulfonyl or aminosulfonyl radicals BASF AKTIENGESELLSCHAFT (DE) 1998-12-22 — — US disclosed
WO-1998028268-A2 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS ELAN PHARMACEUTICALS, INC. (US) 1998-07-02 — — WO disclosed
CN-1026979-C One-step synthesis of tert-butyl threonine UNIV JILIN (CN) 1994-12-14 — — CN disclosed
CN-1026979-C One-step synthesis of tert-butyl threonine UNIV JILIN (CN) 1994-12-14 — — CN disclosed
CN-1041757-A The single stage method of tert-butyl threonine is synthetic UNIV JILIN (CN) 1990-05-02 — — CN disclosed
CN-1041757-A The single stage method of tert-butyl threonine is synthetic UNIV JILIN (CN) 1990-05-02 — — CN disclosed
CN-1041757-A The single stage method of tert-butyl threonine is synthetic UNIV JILIN (CN) 1990-05-02 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220183291-A1 COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY IN PLANTS IFNG, STING1, IRF3 TP53 2726/4885SLC6A4 4816/4885CA2 3646/4885
US-20210386721-A1 SUBSTITUTED PHENYLPROPENYL PYRIDINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL APPLICATIONS PDCD1, CD274, PDCD1LG2 TP53 197/4885SLC6A4 786/4885CA2 3313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.